Exum Instruments and Edge Scientific Announce Strategic Partnership

Providing researchers and facilities with state-of-the-art innovations in mass spectrometry DENVER, CO – Exum Instruments, manufacturer of instruments and software ecosystems that increase the speed of development and discovery, is excited to announce a strategic partnership with Edge Scientific, a leading Canadian distributor of scientific instruments. This collaboration marks a significant milestone for Exum’s growth [...]

Bio-Rad Launches Three StarBright Red Dyes and Expands Range of Antibody Markers Conjugated to StarBright Violet Dyes to Enhance Immunology Research

Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research. HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of three [...]

Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution

Latest addition to the NovoCyte family celebrates a decade of flow cytometry excellence SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse [...]

Padraig McDonnell Assumes Agilent CEO Role

SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. [...]

Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)

Court finds non-infringement by Curio Seeker with respect to over-reaching claim by 10x Genomics PALO ALTO, Calif. ---Curio Bioscience, a leading innovator of high-precision tools for the life sciences industry, today announced that a decision in a court case has been made. The European Unified Patent Court (UPC) today announced a finding that Curio Seeker [...]

Spheryx Welcomes Dr. Kevin Dahl as Director of Technical Operations & Sales

Dr. Kevin Dahl comes to Spheryx with a wealth of experience in analytical instrumentation to be our new Director of Technical Operations and Sales. New York, NY – Spheryx Inc. is pleased to announce that Kevin Dahl, PhD, will be joining Spheryx as Director of Technical Operations and Sales. Kevin joins Spheryx with deep experience [...]

OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research 30 Apr 2024 Technology: NGS

Oxford, UK – OGT, a leading global provider of genomic research and diagnostic solutions, announces the launch of the RNA-based SureSeq™ Myeloid Fusion Panel, a new next-generation sequencing (NGS) tool for identifying key fusion genes implicated in acute myeloid leukaemia (AML). Intelligently designed in collaboration with leading myeloid cancer experts, the SureSeq Myeloid Fusion Panel [...]

Minitool, Inc. sells their product, manufacturing and associated assets to Ted Pella, Inc.

On April 23, 2024, Minitool, Inc. announced that they have sold their product, manufacturing and associated assets to Ted Pella, Inc. Renate and Frank Schaller, the owners of Minitool, Inc. signed the agreement with Tom Pella, owner and president of Ted Pella, Inc. On May 1st, 2024, Minitool, Inc. will cease sales of their products [...]

Reflect Scientific Inc Secures $550,000 Sale with Major BioPharma Company

OREM, Utah -- Reflect Scientific, Inc. (Symbol: RSCF), a leading provider of advanced freezing solutions for the pharmaceutical industry, is pleased to announce a significant sale of its cutting-edge freezer systems to a major biopharmaceutical company. The sale, totaling $550,000, includes multiple systems that were shipped in the first and second quarters of 2024. This [...]

Cytiva introduces new cell lines to meet the challenges and increasing demand of viral vector manufacturing

New offering contains three cell lines to comprehensively meet the objectives of various therapeutic programs and provide the ability to transition between cell lines as needs evolve  Viral vector-based gene therapies hold immense promise for treating a multitude of diseases. However, their widespread adoption has been hindered by inefficient manufacturing methods and the absence of [...]

Access IBO on Knowledge Center